Journal of Nuclear Medicine

Services claiming to be JNM are soliciting authors, editors, and reviewers. Read more to protect yourself.

MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy
177Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial
JNM Podcast Episode 10 – Understanding Metabolic PET Markers Beyond SUV
Entities are misrepresenting themselves as JNM. Read more on how to protect yourself.

Published Ahead of Print

You have access
Whole-Body [¹⁸F]DPA-714 Kinetic Assessment Using PET/CT Scanner with Long Axial Field of View
Xavier Palard-Novello, Denise Visser, Maqsood Yaqub, Elsmarieke van de Giessen, Marijke E. den Hollander, Albert D. Windhorst, Sander C.J. Verfaillie, Hans Knoop, Bart N.M. van Berckel, Sandeep S.V. Golla, Nelleke Tolboom and Ronald Boellaard

Journal of Nuclear Medicine May 29, 2025, jnumed.124.268979; DOI: https://doi.org/10.2967/jnumed.124.268979
Open Access
[¹⁸F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis–Associated Interstitial Lung Disease
David M.L. Lilburn, Helen S. Garthwaite, Balaji Ganeshan, Thida Win, Nicholas J. Screaton, Luke R. Hoy, Darren Walls, Raymond Endozo, Robert I. Shortman, Francesco Fraioli, Athol U. Wells, Christopher P. Denton, Ashley M. Groves and Joanna C. Porter

Journal of Nuclear Medicine May 29, 2025, jnumed.125.269497; DOI: https://doi.org/10.2967/jnumed.125.269497
Open Access
Granzyme B PET Imaging Predicts Response to Immunotherapy in a Diet-Induced Obesity Model of Breast Cancer
Shannon E. Lynch, Corinne Crawford, Addison L. Hunt, Luke L. Sligh, Yujun Zhang, Lyse A. Norian, Benjamin M. Larimer, Suzanne E. Lapi and Anna G. Sorace

Journal of Nuclear Medicine May 29, 2025, jnumed.124.268938; DOI: https://doi.org/10.2967/jnumed.124.268938
You have access
Clinical Outcomes of ¹⁷⁷Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Skeletal Metastases from Neuroendocrine Tumors: Insights from Real-World Experience
Kunal Ramesh Chandekar, Swayamjeet Satapathy, Sanjana Ballal, Madhav Prasad Yadav, Shubha Gadde Ravindra, Sameer Rastogi, Ranjit Kumar Sahoo and Chandrasekhar Bal

Journal of Nuclear Medicine May 29, 2025, jnumed.125.269456; DOI: https://doi.org/10.2967/jnumed.125.269456
You have access
Rethinking Dosimetry: A European Perspective
Johannes Tran-Gia, Francesco Cicone, Michel Koole, Francesco Giammarile, Jonathan Gear, Emmanuel Deshayes, Pablo Minguez Gabiña, Marta Cremonesi, Jonathan Wadsley, Peter Bernhardt, Manuel Bardiès, Silvano Gnesin, Mattias Sandström, Ulrike Garske-Román, Mona-Elisabeth R. Revheim, Frederik A. Verburg, Mark Konijnenberg, Bernd Joachim Krause, Michael Lassmann and Caroline Stokke

Journal of Nuclear Medicine May 22, 2025, jnumed.124.269378; DOI: https://doi.org/10.2967/jnumed.124.269378
You have access
¹⁷⁷Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
Swayamjeet Satapathy, Chandan K. Das, Shikha Goyal, Ashwani Sood, Kannan Periasamy, Piyush Aggarwal, Komal Preet, Shrawan K. Singh, Ravimohan S. Mavuduru, Girdhar S. Bora, Aditya P. Sharma, Gaurav Prakash, Rajender Kumar, Harmandeep Singh and Bhagwant R. Mittal

Journal of Nuclear Medicine May 22, 2025, jnumed.125.269913; DOI: https://doi.org/10.2967/jnumed.125.269913

Featured Articles

MHC-I–Driven Antitumor Immunity Counterbalances Low Absorbed Doses of Radiopharmaceutical Therapy

May 01, 2025
¹⁷⁷Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with...

May 01, 2025
Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy

May 01, 2025
RECIP 1.0: A Roadmap for Clinical Implementation

May 01, 2025
Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases:...

May 01, 2025
Is ²¹¹At Really Happening?

May 01, 2025
A Brief Report on the Results of the 2024 National Survey of Nuclear Medicine Conducted by the...

May 01, 2025
Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine...

May 01, 2025
Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Ethical, Regulatory...

May 01, 2025

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.